Higher expression of human telomerase reverse transcriptase (hTERT) and subsequent activation of telomerase occur during cellular immortalization and are maintained in cancer cells. To understand the mode of hTERT expression in cancer cells, we identified cancer-specific trans-regulatory proteins that interact with the hTERT promoter, using the promoter magnetic precipitation assay coupled with mass spectrometry. The identified proteins include MutS homolog 2 (MSH2), heterogeneous nuclear ribonucleoprotein (hnRNP) D, hnRNP K and grainyhead-like 2 (GRHL2). We noticed a higher expression of these proteins in human oral squamous cell carcinoma (OSCC) cells than in normal cells, which do not exhibit telomerase activity. Knockdown of MSH2, hnRNP D and GRHL2 resulted in a notable reduction of the hTERT promoter activity in tested cancer cells. Silencing of the above genes resulted in a significant reduction of the telomerase activity in OSCC cells. Interestingly, among the four identified genes, silencing of GRHL2 was essential in reducing telomerase activity and viability of tested cancer cells. These results suggest a possible role of GRHL2 in telomerase activation during cellular immortalization.
Introduction
Telomerase is a ribonucleoprotein complex composed of the catalytic protein subunit human telomerase reverse transcriptase (hTERT) and RNA subunit human telomerase RNA, which serves as the template for the synthesis of telomeric DNA (Cairney and Keith, 2008) . Most human tumor cells show a high level of telomerase activity, whereas normal somatic cells display undetectable level of activity (Kim et al., 1994) . This negligible telomerase activity is sharply enhanced when the cells convert to malignant phenotype . The enzyme is also required for cancer cells to maintain their malignant phenotype, and thus the enzyme would be an ideal target for the development of anticancer drugs (Shay and Keith, 2008) . Therefore, detailed understanding of telomerase regulation is necessary to determine the mechanisms of carcinogenesis and to develop novel armaments against cancer.
Telomerase activity is closely associated with hTERT expression, whereas human telomerase RNA is constitutively expressed in cells (Kyo et al., 2000; Yan et al., 2001) . Thus, many studies have focused on the regulation of hTERT expression to investigate the mechanisms of carcinogenesis. These efforts have revealed that hTERT promoter is enriched with transcription factor-binding sites (Poole et al., 2001) . Several transregulatory factors of the proximal hTERT promoter, including Myc/Max heterodimer, HIF-2a, Cbfa1, AP-2b, TAK1 and Sp1/Sp3, have been identified (Deng et al., 2007; Fujiki et al., 2007; Isenmann et al., 2007; Lebel et al., 2007; Lou et al., 2007) . These factors might impose their regulatory roles through direct physical interactions with the cis-elements of the hTERT promoter.
In this study, we identified new cancer-specific transregulatory proteins of the hTERT promoter using the promoter magnetic precipitation (PMP) coupled with mass spectrometry. This approach allowed us to identify numerous proteins that co-precipitate with the hTERT promoter. Among them, MutS homolog 2 (MSH2), heterogeneous nuclear ribonucleoproteins K and D (hnRNPs K and D) and grainyhead-like 2 (GRHL2) were confirmed to be associated with the hTERT promoter in vitro and in vivo. These proteins bind the hTERT promoter preferentially in human oral squamous cell carcinoma (OSCC) cells, which express a high level of telomerase activity, compared with senescent, telomerase-deficient normal human oral keratinocytes (NHOK) or fibroblasts (NHOF).
MSH2 is a component of highly conserved postreplicative DNA mismatch repair system. Its deficiency leads to genetic instability, telomere capping defect and telomerase-independent cell proliferation, indicating its possible role in the regulation of telomerase function (Rizki and Lundblad, 2001; Campbell et al., 2006) . hnRNP D contains two RNA recognition motifs that regulate the stability of specific mRNAs containing AUUUA repeats (Wagner et al., 1998) . hnRNP K is known to function as a transcriptional regulator by direct binding to the cis-regulatory elements within the promoter sequences (Ostrowski et al., 2004; Lynch et al., 2005) . It is of note that its expression is upregulated in OSCC (Roychoudhury and Chaudhuri, 2007) , indicating its involvement in oral carcinogenesis. development (Wilanowski et al., 2002) . The GRH and GRHL possess the DNA-binding domains and are involved in the transcriptional regulation of protective layer formation, such as the outer cuticle of Drosophila and a stratified epithelium in mammals (Stramer and Martin, 2005) . In this study, we show the involvement of MSH2, hnRNP K, hnRNP D and GRHL2 in the transcriptional regulation of the hTERT promoter.
Results
Identification of the putative trans-regulatory proteins of the hTERT promoter We identified the proteins that associate with the hTERT promoter preferentially in telomerase-positive cells by performing the PMP assay. The nuclear extracts from SCC4 and senescent NHOK were incubated with the hTERT promoter fragment immobilized onto paramagnetic Dynabeads. Separation of the DNAbound proteins revealed numerous nuclear proteins differentially precipitated between NHOK and SCC4 cells ( Figure 1a) . We selectively identified the proteins that were present more abundantly in the precipitates of SCC4 compared with those from NHOK. These proteins were excised from the two-dimensional (2D) gel and identified by the mass spectrometry to include MSH2, hnRNPs K and D, and GRHL2.
All four identified proteins were expressed at higher levels in the OSCC cells compared with senescent NHOK (Figure 1b) . Among the normal cells (NHOK and normal human epidermal keratinocytes), actively proliferating cells (population doubling 12-13) showed higher protein expression levels compared with the senescent cultures (population doubling 26-36) (Figure 2) . During cellular immortalization by Bmi-1 and human papillomavirus E6 , MSH2, hnRNP K and GRHL2 expression levels were increased in post-crisis cells (at population doublings 65 and 87) compared with the pre-crisis cells (population doubling 33). The enhanced expression of these proteins coincided with the increased telomerase activity in the post-crisis cells . These results indicate that the identified proteins may contribute to telomerase activation during cellular immortalization by physical interaction with the hTERT promoter regions.
We confirmed the binding of MSH2, hnRNPs K and D, and GRHL2 with the hTERT promoter in vitro by performing the PMP assay followed by western blotting. PMP was performed with the nuclear extracts from NHOF, NHOK, SCC4 and SCC15. As shown in Figure 3a , all four tested proteins were detected in the precipitates, and the level of binding was higher in SCC4 and SCC15 compared with NHOK. It was further reduced or undetectable in NHOF, which completely lack telomerase activity (Kang et al., 1998) , compared with NHOK. These proteins were expressed at comparable levels in NHOK and NHOF and yet yielded differential binding capacity to the hTERT promoter. Figure 1 Identification of human telomerase reverse transcriptase (hTERT) promoter-binding proteins. (a) Nuclear extracts prepared from senescent normal human oral keratinocytes (NHOK) and actively proliferating SCC4 were incubated with the hTERT promoter DNA linked to Dynabeads. Protein-DNA complexes were allowed to form under native conditions and precipitated magnetically. The bound proteins were washed, eluted, fractionated by two-dimensional gel electrophoresis (2DGE) and stained with Sypro Ruby (Bio-Rad). Proteins that were more abundantly precipitated in SCC4 compared with NHOK were identified and excised for mass spectrometric analysis. These proteins were identified as MutS homolog 2 (MSH2), heterogeneous nuclear ribonucleoprotein (hnRNP) K, hnRNP D and grainyhead-like 2 (GRHL2) (arrowheads). (b) Western blotting was performed with NHOK (pre-senescent and senescent cultures) and OSCC cell lines (BaP-T, FaDu, SCC4, 1483, SCC15 and HEp-2) to detect hnRNP K, MSH2, GRHL2 and hnRNP D. b-actin was used as a loading control.
Novel trans-regulators of the hTERT promoter in oral cancer X Kang et al Thus, the protein expression level in cells may not be the sole factor determining the promoter-binding capacity. We also confirmed in vivo DNA-protein interactions by chromatin immunoprecipitation assay for MSH2, hnRNPs K and D, and GRHL2 in NHOK and SCC15 (Figure 3b ). The hTERT promoter region was detected in the immunoprecipitates of all four proteins by PCR amplification. The level of DNA-protein association was notably higher in SCC15 compared with those in NHOK. This result is consistent with the in vitro DNAprotein binding revealed by the PMP assay (Figure 3a) . These experiments confirm the binding of MSH2, hnRNPs K and D, and GRHL2 to the hTERT promoter and indicate the enhanced binding in SCC4 compared with NHOK or NHOF.
To further characterize the association between the identified proteins and the hTERT promoter, we dissected the full-length hTERT fragment (À544 to þ 5) into six overlapping regions and determined the level of protein binding to each region by PMP assay (Figure 4 ). GRHL2 bound strongly in the region 1 (À144 to þ 5) containing the transcription start site. hnRNPs K and D both were localized exclusively in the region 2 (À188 to À42). MSH2 bound most strongly with the region 4 (À377 to À207) and weakly with the regions 1-3, and 5, whereas the region 6 remained unbound. We also explored the binding pattern for Sp1, a protein known to interact with the hTERT promoter (Won et al., 2002) . Sp1 exhibited binding in the region 5 (À465 to À341) and the regions 1 and 2 (together covering from À188 to þ 5). These results indicate that MSH2, hnRNPs K and D, and GRHL2 bind the hTERT promoter regions in a sequence-specific manner.
The hTERT promoter binding proteins regulate the hTERT promoter activity The biological functions of MSH2, hnRNP K, hnRNP D and GRHL2 were investigated for their role in the regulation of hTERT expression. We knocked down their expression in actively proliferating SCC4 cells, which express these genes at high levels ( Figure 1b) . We used the validated small interfering RNAs (siRNAs) targeting MSH2, hnRNP K or hnRNP D. To knockdown the expression of GRHL2, we constructed a lentiviral vector expressing short hairpin RNA against GRHL2 (LV-GRHL2i). SCC4 cells were either transfected with siRNAs or infected with LV-GRHL2i. After 3 days of RNAi, the cells were harvested and successful knockdown was confirmed by either western blotting or semi-quantitative RT-PCR ( Figure 5a ). We also determined the short-term effects of RNAi for the individual genes on cell proliferation. With an exception of MSH2, knockdown of all other gene expression individually led to varying degrees of cell proliferation arrest ( Figure 5b ).
To determine the role of these genes in hTERT promoter regulation, we used the hTERT promoterluciferase reporter construct (pGL3B-TRTP) that was Novel trans-regulators of the hTERT promoter in oral cancer X Kang et al transfected into SCC4 cells after the transfection of the siRNAs targeting MSH2, hnRNP K or hnRNP D. The reporter construct was also transfected into the cells infected with LV-EGFP or LV-GRHL2i. After 2 days of post-transfection, firefly luciferase reporter activity was determined. Knockdown of MSH2, the hnRNPs or GRHL2 all led to the reduction of the luciferase activity, although to varying degrees ranging from approximately 10-90% ( Figure 6a ). We also constructed a mutant hTERT promoter lacking the sequences from À49 to þ 5 (pGL3-hTERTpD(À49 to þ 5)), which contains the region that GRHL2 binds (Figure 4 ). To determine the effects of deleting these sequences on hTERT promoter activity, we transfected the wild-type (pGL3B-TRTP) or the mutant hTERT promoterluciferase constructs into SCC4 cells with or without GRHL2 knockdown. The deletion mutant completely abolished the hTERT promoter activity (Figure 6b ). Furthermore, GRHL2 knockdown led to a significant diminution of the hTERT mRNA expression, although knockdown of MSH2 or the hnRNPs did not (Figure 6c ).
Effects of MSH2, the hnRNPs and GRHL2 RNAi on telomerase activity in SCC4 cells
We determined whether MSH2, the hnRNPs and GRHL2 play a role in the regulation of telomerase activity by knocking down their expression in SCC4 cells. After 3 days of individual gene knockdown of MSH2, hnRNP K or hnRNP D, there was little or no significant change in the telomerase activity in SCC4 cells (data not shown). Subsequently, we administered combined RNAi by using the SCC4 cells stably infected with LV-EGFP or LV-GRHL2i, which were then transfected with varying combinations of siRNAs. Marked reduction of telomerase activity was noted in SCC4 cells infected with LV-GRHL2i after knockdown of hnRNP K, whereas the other siRNA combinations Figure 4 MutS homolog 2 (MSH2), the heterogeneous nuclear ribonucleoproteins (hnRNPs) and grainyhead-like 2 (GRHL2) bind the human telomerase reverse transcriptase (hTERT) promoter in a sequence specific manner. The hTERT promoter (À544 to þ 5) was amplified into six overlapping regions with the forward primer conjugated with biotin at the 5 0 -end. The hTERT promoter fragments representing the six regions were used to determine the regions at which the identified proteins interact with the hTERT promoter. Promoter magnetic precipitation (PMP) assay was performed with nuclear extracts isolated from actively dividing SCC4 cells. The precipitated proteins were eluted, fractionated by SDS-polyacrylamide gel electrophoresis, and subjected to western blotting for MSH2, hnRNP K, hnRNP D and GRHL2. For comparison, we also included Sp1, which is known to interact with the proximal hTERT promoter region (Won et al., 2002) . Novel trans-regulators of the hTERT promoter in oral cancer X Kang et al showed little effect (Figures 7a-c) . This experiment was repeated using a different OSCC line, SCC15. In these cells, however, GRHL2 knockdown alone led to notable reduction of the telomerase activity. Thus, RNAi of GRHL2 alone appears to be sufficient for the telomerase inhibition in some OSCC cells. The inhibitory effect of GRHL2 and hnRNP K on telomerase activity was in part correlated with the proliferation and viability status of SCC4 cells (Figure 8) . The cells showed a significant reduction in cell proliferation after infection with LV-GRHL2i compared with those infected with LV-EGFP. Cell proliferation and viability were further inhibited after additional knockdown of MSH2, hnRNP K and/or hnRNP D. Taken together, the above findings confirm the biological functions of the identified hTERT promoter-binding proteins in regulation of the hTERT promoter activity, telomerase activity, cell proliferation and viability of SCC4 cells.
Discussion
In this study, we show that MSH2, the hnRNPs K and D, and GRHL2 are the novel proteins that physically associate with the hTERT promoter and regulate the promoter activity. This study confirmed the validity of PMP coupled with mass spectrometry in the identification of DNA-binding proteins. This unique combination of high-throughput techniques is a powerful approach for the identification of new hTERT trans-regulatory proteins through the specific protein-DNA interactions. PMP served as the primary screening to enrich the candidate DNA-binding proteins from the nuclear extract. This resulted in a dramatic reduction of the sample complexity, as shown in Figure 1a , when the magnetically precipitated proteins were fractionated by 2D gel electrophoresis. The data also showed the presence of numerous low abundance proteins in both NHOK and SCC4 samples that could not reliably be identified. These proteins would require an additional concentration or fractionation of the PMP samples for further characterization.
We found that the wild-type hTERT promoter activity was significantly reduced by the knockdown of GRHL2. In addition, the mutant hTERT promoter activity was completely abolished in the presence or absence of GRHL2 expression in cells. This data indicate that the region from À49 to þ 5 is critical for the hTERT promoter activity. It remains possible that this region interacts with other trans-regulatory proteins than GRHL2, which are necessary for hTERT expression. As the exact hTERT promoter-binding site of GRHL2 is unknown, further studies are needed to elucidate the effects of GRHL2 binding alone on the hTERT promoter activity. Novel trans-regulators of the hTERT promoter in oral cancer X Kang et al Our study revealed the inhibitory effects of the gene knockdown on cell proliferation and the hTERT promoter luciferase activity for all four genes tested, although to varying degrees (Figures 5b and 6a) . Knockdown of hnRNP K, hnRNP D or GRHL2 alone resulted in a significant reduction of cell proliferation in SCC4 cells. GRHL2 knockdown led to congruent loss of telomerase activity (Figure 7) . We also found that overexpression of GRHL2 in primary NHOK prevented the senescence-associated loss of telomerase activity (Kang et al., 1998 (Kang et al., , 2004 , and the cells expressing exogenous GRHL2 showed enhanced cellular proliferation (data not shown). However, knockdown of the hnRNPs revealed no effect on telomerase activity. Thus, reduced cell proliferation by silencing of the hnRNPs may represent telomerase-and/or telomere-independent event. Furthermore, with an exception of GRHL2, knockdown of MSH2 or the hnRNPs did not result in a congruent reduction of the mRNA expression level. These genes possess diverse biological functions that may lead to altered RNA stability and post-transcriptional processing. This is especially true for the hnRNPs, which are known as RNA-binding proteins. hnRNP D is an RNA turnover factor that modulates the decay of AU-rich mRNAs (Kiledjian et al., 1997; He and Schneider, 2006) . hnRNP K regulates the multitude of gene expression, including that of p53 (Moumen et al., 2005) , as a transcription factor or by alteration of mRNA stability and translation (Ostareck- Lederer and Ostareck, 2004) . Thus, we cannot rule out the possibility that RNAi against the hnRNPs indirectly led to stabilization of hTERT mRNA, resulting in the apparent discrepancy between the promoter activity and the mRNA level.
We found that MSH2, the hnRNPs and GRHL2 bind to the hTERT promoter in a sequence-specific manner (Figure 4) . With an exception of MSH2, binding of the hnRNPs and GRHL2 to the hTERT promoter occurred within the regions 1 and 2 covering the sequences from À188 to þ 5 from the transcription start site. Knockdown of these genes led to notable reduction of the promoter activity, consistent with an earlier report After 72 h posttransfection, the cells were harvested and TRAP assay was performed. Telomerase activity was quantitated and normalized against the control group (without the extract). Reduction of telomerase activity was evidenced in the groups in which both GRHL2 and hnRNP K were knocked down.
Novel trans-regulators of the hTERT promoter in oral cancer X Kang et al showing the minimum sequence requirement for the full promoter activity within these regions (Cong et al., 1999) . The PMP assay also revealed an Sp1 binding in these regions in agreement with other studies that showed the proximal location of the Sp1-binding sites (Cong et al., 1999; Kyo et al., 2000) . We also identified a novel binding site for Sp1 distally located in the region 5 (À465 to À341), although its functional significance for the promoter regulation remains to be determined. The Sp1-binding sites within the proximal regions are necessary for the full activity of the hTERT promoter, which apparently lack TATA or CAAT box (Cong et al., 1999; Kyo et al., 2000) . Sp1 interacts with the basal transcription machineries, such as TATA boxbinding protein and TATA box-binding protein-associated factors, to help to initiate the transcription of TATA less promoters (Emili et al., 1994; Suzuki et al., 2003) . However, Sp1 may also impose inhibitory effects on the promoter by recruiting histone deacetylases (Won et al., 2002) . Histone deacetylases recruitment and abundance on the hTERT promoter are associated with transcriptional repression, presumably by maintaining the condensed chromatin state (Zhu et al., 2008) . These results point out the complexity in the modes by which Sp1 regulates the hTERT promoter activity. Although individual gene knockdown had no detectable effect on telomerase activity, multiple gene silencing involving at least GRHL2 and hnRNP K led to notable reduction of telomerase activity in SCC4 cells. GRHL2 knockdown alone led to a significant loss of telomerase activity in SCC15 cells. The reason for the different requirement for telomerase activity in SCC4 and SCC15 cells is unknown. In both cells, however, GRHL2 appears to be a critical factor for hTERT expression and telomerase activity. This notion is also reinforced by the result showing that GRHL2 binds the hTERT promoter DNA in a close proximity to the transcription start site (Figure 4 ). GRHL2 knockdown in NHOK alone led to reduced hTERT mRNA expression and telomerase activity (data not shown). Further studies will elucidate the role of GRHL2 in the regulation of hTERT expression and telomerase activity.
RNAi-mediated loss of telomerase activity in SCC4 cells occurred with reduced cell viability and proliferative status. This does not appear to be an artifact of nonspecific toxicity as it can be evinced in the cells infected with LV-GHRL2i and treated with MSH2 siRNA. These cells showed a similar extent of proliferation defect as those treated with hnRNP K RNAi (Figure 8 ), but expressed intact telomerase activity (Figure 7) . Similarly, those infected with LV-EGFP and exposed to the siRNAs showed varying degrees of cell proliferation arrest and loss of viability, yet retained intact telomerase activity in the adherent cells. Thus, these groups of cells illustrate a disconnect between telomerase activity and the cell viability status, and support the notion that the loss of telomerase activity reported herein is not an artifact of nonspecific toxicity from multiple gene knockdown.
In summary, we report MSH2, the hnRNPs and GRHL2 as novel hTERT promoter-binding proteins identified by the PMP assay. This approach coupled with proteomic techniques is a powerful combination of HTS for DNA-binding proteins, ideally suited for Novel trans-regulators of the hTERT promoter in oral cancer X Kang et al exploring the trans-regulatory factors. These proteins were highly overexpressed in the OSCC cells compared with NHOK, indicating their aberrant expression associated with oral carcinogenesis. Elevation of their expression was observed during the transition from preto post-crisis, at which telomerase activation occurred . As these proteins were necessary for the intact expression of the hTERT promoter activity in OSCC cells, we speculate that they are in part responsible for the elevated hTERT expression and telomerase activation during oral carcinogenesis.
Materials and methods
Cells and cell culture Primary NHOK and NHOF were prepared from keratinized oral epithelial tissues according to the methods described elsewhere (Park et al., 1991; Kang et al., 1998) . Normal human epidermal keratinocytes were prepared from the foreskin epithelium. Primary NHOK and normal human epidermal keratinocytes were maintained in a keratinocyte basal medium supplemented with the growth factor bullet kit (Lonza Biologicals Inc., Portsmouth, NH, USA) or EpiLife supplemented with HKGS (Invitrogen, Carlsbad, CA, USA). These cells were serially subcultured until they reached the senescent stage as reported earlier (Kang et al., 1998) . The pre-and post-crisis HOK were obtained from NHOK infected sequentially with the retroviral vectors expressing Bmi-1 and the E6 oncoprotein of human papillomavirus type 16 . Human OSCC cell lines (SCC4, SCC9, SCC15, HEp-2, FaDu, BaP-T and 1483) were cultured according to the methods described earlier (Kang et al., 1998) .
PMP assay PMP was performed with the late passage (senescing) NHOK culture and SCC4 cells, which represented telomerase-negative and -positive cells, respectively (Kang et al., 1998) . Biotinylated hTERT promoter (549 bp) was PCR-amplified using the forward primer 5 0 -CTCCGTCCTCCCCTTCAC-3 0 and the reverse primer 5 0 -ATCGATCAGCGCTGCCTGAAACTC-3 0 with biotin conjugation on the 5 0 -end of the forward primer. The hTERT promoter fragment was conjugated with Dynabeads (Invitrogen). The PMP assay was performed by incubating the immobilized hTERT promoter fragment with the nuclear extracts (20 or 200 mg) precleared with unconjugated Dynabeads in the presence of poly (dI:dC). After 1 hr incubation at room temperature, the beads were collected by the magnetic apparatus and washed with the binding buffer containing 0.5% Nonidet P-40. Proteins that were coprecipitated were eluted in the SDS sample buffer or 2D sample buffer and fractionated in 8-16% gradient SDS-polyacrylamide gel electrophoresis (PAGE) or by 2D gel electrophoresis.
For the regional analysis of the hTERT promoter, the 549-bp hTERT promoter was amplified into six overlapping regions using specific primer sets. The sequence of the primers and PCR conditions can be available upon request. The PMP analysis was performed using the nuclear extracts of SCC4 cells. Subsequently, western blotting was performed to identify specific proteins in the magnetic precipitates.
Western blotting Whole cell extracts from cultured cells were fractionated by SDS-PAGE and transferred to Immobilon protein membrane (Millipore, Billerica, MA, USA). Immobilized membrane was incubated with the primary antibodies, that is, hnRNP K (Zymed Laboratories, South San Francisco, CA, USA), hnRNP D (Aviva Systems Biology, San Diego, CA, USA), MSH2 (Calbiochem, San Diego, CA, USA), GRHL2 (Abnova, Taipei, Taiwan), Sp1 (Santa Cruz Biotech., Santa Cruz, CA, USA) and b-actin (Santa Cruz Biotech.) and probed with the respective secondary antibodies.
2D gel electrophoresis
The proteins co-precipitated with the hTERT promoter were subjected to 2D gel electrophoresis, which involved firstdimension separation by isoelectric focusing (IEF) using immobilized pH gradient strips (7-cm long, linear pH 3-10/ pH 5-8) from Bio-Rad (Hercules, CA, USA) and seconddimension separation by gradient SDS-PAGE. Isoelectric focusing followed a stepwise incremental voltage program: 250 V for 15 min, 250-4000 V for 2 h, 4000 V for 5 h and hold at 500 V using the isoelectric focusing cell (Bio-Rad). After isoelectric focusing, the strips were subjected to two-step equilibration in equilibration buffers containing 6 M urea, 30% glycerol, 2% SDS, 50 mM Tris-HCl and pH 8.8 with 1% DTT w/v for the first step, and 2.5% (w/v) iodoacetamide for the second step. The strips were then transferred onto 8-16% gradient SDS-PAGE gel (Invitrogen) and electrophoresed. The protein spots were stained with Sypro Ruby (Bio-Rad).
Protein identification by mass spectrometry
The protein spot patterns from 2D gel electrophoresis were compared between NHOK and SCC4 cells. The protein spots were excised by the Proteome Works Spot Cutter System (Bio-Rad) and analysed by Applied Biomics Inc. (Hayward, CA, USA). Proteins of interest were digested in-gel with modified porcine trypsin protease (Trypsin Gold, Promega, Madison, WI, USA). MALDI-TOF MS and TOF/TOF tandem MS/MS were performed on an ABI 4700 mass spectrometer (Applied Biosystems, Framingham, MA, USA). The peptide mass and associated fragmentation spectra were submitted to the GPS Explorer workstation equipped with a MASCOT search engine (Matrix Science, Boston, MA, USA) to search National Center for Biotechnology Information nonredundant (NCBInr). Candidates with either protein score CI% or ion CI% greater than 95 were considered significant.
RT-PCR
Total RNA was isolated from the cultured cells using RNeasy Mini Kit (Qiagen, Chatsworth, CA, USA). The RT reaction was performed with 5 mg total RNA, and the PCR reactions were performed for hTERT, hnRNP D, GRHL2 and glyceraldehyde 3-phosphate dehydrogenase in a semi-quantitative manner. The PCR amplification was performed with primer sequences were 5 0 -GCCTGAGCTGTACTTTGTCAA-3 
Chromatin immunoprecipitation assay
We performed chromatin immunoprecipitation assay using the commercial kit (Upstate, Temecula, CA, USA) according to the manufacturer's guidelines. Rapidly proliferating SCC4 cells were exposed to 1% formaldehyde, and chromatin was fragmented by sonication. Immunoprecipitation was performed using IgG (negative control) or with the primary antibodies for hnRNP K, hnRNP D, MSH2 or GRHL2 as described above. DNA was purified from the immunoprecipitates using the PCR purification kit (Qiagen). Subsequently, PCR was performed to amplify the hTERT promoter region using the primers 5 0 -TTTGGGCTAGTCTGGGGCGGGG-3 0 (forward) and 5 0 -GGCGCCCCCCAGCAGCTTAGGC-3 0 (reverse). The PCR products were separated by agarose gel electrophoresis and stained with ethidium bromide.
Protein function analysis by RNAi Endogenous GRHL2 expression was knocked down by RNAi using short hairpin RNA. GRHL2 short hairpin RNA target sequences were identified by Ambion-siRNA Database and Design Tools (http://www.ambion.com/techlib/misc/ siRNA_tools.html). We constructed a lentiviral vector expressing GRHL2 short hairpin RNA (LV-GRHL2i) for the internal GRHL2 sequence of 5 0 -GAGATTGCATATAA TGCTG-3 0 using pLentilox 3.7 plasmid (AddGene Inc., Cambridge, MA, USA). LV-GRHL2i and the LV-EGFP (empty vector) were produced and concentrated as described earlier . These viral vectors were used to infect SCC4 or SCC15 cells. Virus infection was allowed for 4 h in the presence of 6 mg/ml polybrene (Sigma, St Louis, MO, USA). Infected SCC4 cells were cloned by limiting dilution in 96-well plates. Knockdown of endogenous hnRNP K, hnRNP D and MSH2 were performed using the validated doublestranded siRNAs (Santa Cruz Biotech.). The siRNAs were transfected into the cultured cells according to the manufacturer's guidelines. Successful knockdown of gene expression was confirmed after 72 h post-transfection.
Transfection and reporter gene assay A pGL3B-TRTP containing the 1670-bp fragment (À1665 to þ 5) of the hTERT promoter region linked to firefly luciferase cDNA (gift of Dr JC Barrett, NIEHS/NIH, Bethesda, MD, USA) was used for the hTERT promoter reporter assay. Before transfection, a six-well plate with approximately 5 Â 10 4 cells per well was inoculated and cultured for 24 h. pGL3B-TRTP (1 mg per each well) was introduced into cells using Lipofectin Reagent (Invitrogen). To control for the different transfection efficiencies, pRL-SV40 plasmid (1 ng per each well) containing the Renilla luciferase cDNA under the control of SV40 enhancer/promoter was also transfected into each cell group. Cells were collected after 48 h post-transfection, and the cell lysates were prepared using the Dual Luciferase Reporter Assay System (Promega, Madison, WI, USA). Luciferase activity was measured using a luminometer (Turner Designs, Sunnyvale, CA, USA).
We also constructed a mutant hTERT promoter with deletion from À49 to þ 5 (pGL3-hTERTpD(À42 to þ 5), which contains the GRHL2 binding region. Owing to the existing XhoI site immediately downstream of the hTERT promoter sequence, the deletion was made by first creating a new XhoI site at À50 using QuikChange multi site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA). The plasmid was then digested with XhoI and allowed to self-ligate. The wild-type hTERT promoter construct (pGLB-TRPT) and the mutant promoter construct were transfected into rapidly proliferating SCC4 cells, and the promoter activities were compared by luciferase activity. Transfection efficiencies were normalized by the Renilla luciferase activity.
Telomerase assay
Telomerase activity was detected using the TRAP-eze Telomerase Detection Kit (Chemicon, Temecula, CA, USA) according to manufacturer's guidelines. This kit allows for semi-quantitative detection of telomerase activity and amplification of the internal controls. Whole cell extract isolated in 1 Â CHAPS buffer was used with the TRAP reaction mixture in the two-step telomerase assay involving the PCR amplification (Kim et al., 1994) . The PCR products were separated by 12.5% PAGE. The radioactive signal was detected by Phosphor Imager (Molecular Dynamix Inc., Sunnyvale, CA, USA).
